"
Team:Imperial College London/M2
From 2009.igem.org
(Difference between revisions)
(→Module 2 Contents) |
|||
| Line 18: | Line 18: | ||
<br> | <br> | ||
| + | |||
| + | <html><center><a href="https://2009.igem.org/Team:Imperial_College_London/M1"><img width=150px src="https://static.igem.org/mediawiki/2009/4/4d/II09_M2ArrowLeft.png"></a><a href="https://2009.igem.org/Team:Imperial_College_London/M3"><img width=150px src="https://static.igem.org/mediawiki/2009/a/af/II09_M2ArrowRight.png"></a></center> | ||
| + | </html> | ||
{{Imperial/09/Division}} | {{Imperial/09/Division}} | ||
<br> | <br> | ||
| Line 48: | Line 51: | ||
<br> | <br> | ||
| - | |||
| - | |||
Revision as of 13:59, 9 October 2009
Module 2 - Encapsulsation
Overview
Aside from aiding in pill manufacture, encapsulation (Module 2) allows the safe passage of polypetides through the stomach into the intestine. The encapsulation process involves the production of a physical barrier, acid resistance proteins and the preservative trehalose. Without encapsulation, our polypeptides would be denatured and degraded by stomach acid and digestive proteases respectively.
About proteolysis.
Our solution represents a fusion between probiotic treatment & polypeptide encapsulation
